T Cell News and Research

Latest T Cell News and Research

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

25 Sep 2014

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children.

25 Sep 2014

NIH awards grants to 11 research groups to establish AMP RA/Lupus Network

The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network.

25 Sep 2014

Antacids linked to reduced erlotinib efficacy

Acid suppression therapy may negatively impact outcome among patients receiving erlotinib for advanced non-small-cell lung cancer, Canadian study findings show.

24 Sep 2014

Research report on biopharmaceutical and vaccine manufacturing markets

The total biopharmaceutical manufacturing market is growing, according to Kalorama Information's report, Biopharmaceutical and Vaccine Production Markets.

24 Sep 2014

Case Western Reserve University’s synchrotron facility to become No. 1 beamline facility for biology

Case Western Reserve University’s synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.

24 Sep 2014

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

ImmunoCellular Therapeutics, Ltd. announced today that it has established a licensing agreement with the California Institute of Technology for exclusive rights to novel technology for the development of certain antigen specific T-cell immunotherapies for the treatment of cancer.

24 Sep 2014

Researchers explore gene expression in normal vestibular nerves, vestibular schwannomas

Researchers from the University of Toronto, directed by Drs. Gelareh Zadeh and Boris Krischek, investigated gene expression in normal vestibular nerves and vestibular schwannomas (VSs).

24 Sep 2014

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research and the Catalan Institute of Oncology was established with the aim of bringing the company the latest scientific developments to the service combating cancer with two main branches: the development of new drugs and advance the implementation of personalized cancer treatments.

24 Sep 2014

New pediatric heart-defect patches enhance electrical connections between cells

Carbon nanotubes serve as bridges that allow electrical signals to pass unhindered through new pediatric heart-defect patches invented at Rice University and Texas Children's Hospital.

24 Sep 2014

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.

24 Sep 2014

UC Riverside collaborating on NSF-funded project to study ancient lineages of fungi

The University of California, Riverside is one of 11 collaborating institutions that have been funded a total of $2.5 million by the National Science Foundation for a project focused on studying zygomycetes - ancient lineages of fungi that include plant symbionts, animal and human pathogens and decomposers of a wide variety of organic compounds.

24 Sep 2014

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

A new study published in the prestigious publication The EMBO Journal shows that the mitochondrial protein Mfn2 may be a future therapeutic target for neuronal death reduction in the late phases of an ischemic stroke.

24 Sep 2014

Scientists identify way to find proverbial needle in cancer antigen haystack

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

24 Sep 2014

Rice University research yields new two-step strategy for weakening cancer

Research by Rice University scientists who are fighting a cyberwar against cancer finds that the immune system may be a clinician's most powerful ally.

24 Sep 2014

UW-Madison and Morgridge researchers are creating tissue chip technology to screen neural toxins

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.

24 Sep 2014

Alectinib promise for crizotinib-resistant NSCLC

Alectinib has shown promising antitumour activity in patients with ALK-rearranged non-small-cell lung cancer that is resistant to crizotinib, researchers report.

23 Sep 2014

Scientists identify gene mutation that causes aplastic anemia

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells.

23 Sep 2014

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

EKF, announces that it has entered into a two year research collaboration with Massachusetts General Hospital.

From EKF Diagnostics 23 Sep 2014

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

Arthur W. Perry, MD, FACS, a New Jersey based board-certified plastic surgeon, is the first physician in the Central New Jersey region to offer UltraShape™, a revolutionary treatment recently FDA cleared for Fat Cell Destruction.

23 Sep 2014

T Cell News and Research

Latest T Cell News and Research

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

NIH awards grants to 11 research groups to establish AMP RA/Lupus Network

Antacids linked to reduced erlotinib efficacy

Research report on biopharmaceutical and vaccine manufacturing markets

Case Western Reserve University’s synchrotron facility to become No. 1 beamline facility for biology

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

Researchers explore gene expression in normal vestibular nerves, vestibular schwannomas

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

New pediatric heart-defect patches enhance electrical connections between cells

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

UC Riverside collaborating on NSF-funded project to study ancient lineages of fungi

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

Scientists identify way to find proverbial needle in cancer antigen haystack

Rice University research yields new two-step strategy for weakening cancer

UW-Madison and Morgridge researchers are creating tissue chip technology to screen neural toxins

Alectinib promise for crizotinib-resistant NSCLC

Scientists identify gene mutation that causes aplastic anemia

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in